Profil

BEHRMANN Iris

University of Luxembourg > Faculty of Science, Technology and Medicine (FSTM) > Department of Life Sciences and Medicine (DLSM)

Main Referenced Co-authors
Heinrich, P. C. (38)
HAAN, Claude  (32)
KREIS, Stephanie  (18)
HAAN, Serge  (15)
WURTH - MARGUE, Christiane  (14)
Main Referenced Keywords
Humans (47); Animals (34); Signal Transduction (32); Interleukin-6 (23); Protein-Tyrosine Kinases (21);
Main Referenced Unit & Research Centers
Department of Life Sciences and Medicine (2)
ULHPC - University of Luxembourg: High Performance Computing (2)
University of Luxembourg (2)
Life Science Research Unit-University of Luxembourg (1)
Luxembourg Centre for Systems Biomedicine (LCSB): Metabolomics (Hiller Group) (1)
Main Referenced Disciplines
Biochemistry, biophysics & molecular biology (87)
Gastroenterology & hepatology (1)
Microbiology (1)
Life sciences: Multidisciplinary, general & others (1)

Publications (total 90)

The most downloaded
1379 downloads
Haan, C., & Behrmann, I. (2007). A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. Journal of Immunological Methods, 318 (1-2), 11-9. doi:10.1016/j.jim.2006.07.027 https://hdl.handle.net/10993/6227

The most cited

2653 citations (Scopus®)

Heinrich, P. C.* , Behrmann, I.* , Haan, S.* , Hermanns, H. M.* , Müller-Newen, G.* , & Schaper, F.*. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochemical Journal, 374 (Pt 1), 1-20. doi:10.1042/BJ20030407 https://hdl.handle.net/10993/794

KIRCHMEYER, M.* , GAIGNEAUX, A.* , SERVAIS, F., Arslanow, A., Casper, M., Krawczyk, M., Lammert, F., & BEHRMANN, I. (2023). Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3I148M risk allele. Hepatology Communications. doi:10.1097/HC9.0000000000000306
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Kirchmeyer, M., Servais, F., Ginolhac, A., Nazarov, P. V., Margue, C., Philippidou, D., Nicot, N., Behrmann, I., Haan, C., & Kreis, S. (2020). Systematic transcriptional profiling of responses to STAT1- and STAT3- activating cytokines in different cancer types. Journal of Molecular Biology. doi:10.1016/j.jmb.2020.09.011
Peer Reviewed verified by ORBi

Walbrecq, G., Margue, C., Behrmann, I., & Kreis, S. (2020). Distinct Cargos of Small Extracellular Vesicles Derived from Hypoxic Cells and Their Effect on Cancer Cells. International Journal of Molecular Sciences. doi:10.3390/ijms21145071
Peer Reviewed verified by ORBi

Walbrecq, G., Lecha, O., Gaigneaux, A., Fougeras, M. R., Philippidou, D., Margue, C., Tetsi Nomigni, M., Bernardin, F., Dittmar, G., Behrmann, I., & Kreis, S. (2020). Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles. Cancers. doi:10.3390/cancers12030692
Peer Reviewed verified by ORBi

Fernández-Tussy, P., Fernández-Ramos, D., Lopitz-Otsoa, F., Simón, J., Barbier-Torres, L., Gomez-Santos, B., Nuñez-Garcia, M., Azkargorta, M., Gutiérrez-de Juan, V., Serrano-Macia, M., Rodríguez-Agudo, R., Iruzubieta, P., Anguita, J., Castro, R. E., Champagne, D., Rincón, M., Elortza, F., Arslanow, A., Krawczyk, M., ... Martinez_Chantar, M. (2019). miR-873-5p targets mitochondrialGNMT-Complex II interface contributing tonon-alcoholic fatty liver disease. Molecular Metabolism. doi:10.1016/j.molmet.2019.08.008
Peer reviewed

Servais, F., Kirchmeyer, M., Hamdorf, M., Minoungou, W. N., Rose-John, S., Kreis, S., Haan, C., & Behrmann, I. (2019). Modulation of the IL-6 signaling pathway in liver cells by miRNAs targeting gp130, JAK1 and/or STAT3. Molecular Therapy: Nucleic Acids, 16, 419-433. doi:10.1016/j.omtn.2019.03.007
Peer Reviewed verified by ORBi

Rolvering, C., Zimmer, A. D., Ginolhac, A., Margue, C., Kirchmeyer, M., Servais, F., Hermanns, H. M., Hergovits, S., Nazarov, P. V., Nicot, N., Kreis, S., Haan, S., Behrmann, I., & Haan, C. (2018). The PD-L1- and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by a-PD-L1 or a-IL6 antibodies. Journal of Leukocyte Biology, 104, 969-985. doi:10.1002/JLB.MA1217-495R
Peer Reviewed verified by ORBi

Kirchmeyer, M., Servais, F., Hamdorf, M., Nazarov, P. V., Ginolhac, A., Halder, R., Vallar, L., Glanemann, M., Rubie, C., Lammert, F., Kreis, S., & Behrmann, I. (2018). Cytokine-mediated modulation of the hepatic miRNome: miR-146b-5p is an IL-6-inducible miRNA with multiple targets. Journal of Leukocyte Biology. doi:10.1002/JLB.MA1217-499RR
Peer Reviewed verified by ORBi

Rolvering, C., Zimmer, A., Kozar, I., Hermanns, Letellier, E., Vallar, L., Nazarov, P., Nicot, N., Ginolhac, A., Haan, S., Behrmann, I., & Haan, C. (2017). Crosstalk between different family members: IL27 recapitulates IFNγ responses in HCC cells, but is inhibited by IL6-type cytokines. BBA Molecular Cell Research, 516-526. doi:10.1016/J.BBAMCR.2016.12.006
Peer Reviewed verified by ORBi

Bongartz, H., Hessenkemper, W., Müller, C., Fensky, M., Fritsch, J., Mandel, K., Behrmann, I., Haan, C., Fischer, T., Feller, S. M., & Schaper, F. (2017). The multi-site docking protein Gab1 is constitutively phosphorylated independent from its recruitment to the plasma membrane in Jak2-V617Fpositive cells and mediates proliferation of human erythroleukaemia cells. Cellular Signalling, 35, 37-47. doi:10.1016/j.cellsig.2017.03.021
Peer reviewed

Zimmer, A. D., Walbrecq, G., Kozar, I., Behrmann, I., & Haan, C. (2016). Phosphorylation of the PDH complex precedes HIF-1-mediated effects and PDK1 upregulation during the first hours of hypoxic treatment in HCC cells. Hypoxia, 4, 135-145. doi:10.2147/HP.S99044
Peer reviewed

Casper, M., Krawczyk, M., Behrmann, I., Glanemann, M., & Lammert, F. (2016). Variant PNPLA3 increases the HCC risk: prospective study in patients treated at the Saarland University Medical Center. Zeitschrift für Gastroenterologie, 54, 585-586. doi:10.1055/s-0042-106308
Peer Reviewed verified by ORBi

Battello, N., Zimmer, A. D., Goebel, C., Dong, X., Behrmann, I., Haan, C., Hiller, K., & Wegner, A. (2016). The role of HIF-1 in oncostatin M-dependent metabolic reprogramming of hepatic cells. Cancer and Metabolism, 4, 3. doi:10.1186/s40170-016-0141-0
Peer Reviewed verified by ORBi

Behrmann, I., Margue, C., & Kreis, S. (2015). Circulating microRNAs as candidate biomarkers for the surveillance of melanoma patients. EBioMedicine. doi:10.1016/j.ebiom.2015.07.015
Peer reviewed

Margue, C., Reinsbach, S., Philippidou, D., Beaume, N., Walters, C., Schneider, J., Nashan, D., Behrmann, I., & Kreis, S. (2015). Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer? Oncotarget, 6 (14), 12110-27. doi:10.18632/oncotarget.3661
Peer Reviewed verified by ORBi

Servais, F., Kirchmeyer, M., Hamdorf, M., Haan, C., Casper, M., Lammert, F., Nazarov, P., Vallar, L., Kreis, S., & Behrmann, I. (2015). ID: 194: Role of microRNAs in signal transduction pathways of the inflammatory cytokine Interleukin-6: Relevance for liver diseases. Cytokine, 76 (1), 99. doi:10.1016/j.cyto.2015.08.198
Peer reviewed

Margue, C., Philippidou, D., Reinsbach, S., Schmitt, M., Behrmann, I., & Kreis, S. (05 September 2013). New Target Genes of MITF-Induced microRNA-211 Contribute to Melanoma Cell Invasion. PLoS ONE, 8 (9). doi:10.1371/journal.pone.0073473
Peer Reviewed verified by ORBi

Gäbler, K., Behrmann, I., & Haan, C. (2013). JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms. JAK-STAT, 2 (3), 25025. doi:10.4161/jkst25025
Peer reviewed

Wolf, A., Eulenfeld, R., Gäbler, K., Rolvering, C., Haan, S., Behrmann, I., Denecke, B., Haan, C., & Schaper, F. (2013). JAK2-V617F-induced MAPK activity is regulated by PI3K and acts synergistically with PI3K on the proliferation of JAK2-V617F-positive cells. JAK-STAT, 2 (3), 24574. doi:10.4161/jkst.24574
Peer reviewed

Gäbler, K., Rolvering, C., Kaczor, J., Eulenfeld, R., Méndez, S. A., Berchem, G., Palissot, V., Behrmann, I., & Haan, C. (2013). Cooperative effects of Janus and Aurora kinase inhibition by CEP701 in cells expressing Jak2V617F. Journal of Cellular and Molecular Medicine, 17 (2), 265-276. doi:10.1111/jcmm.12005
Peer reviewed

Schmitt, M., Margue, C., Behrmann, I., & Kreis, S. (2012). MiRNA-29: A microRNA family with tumor-suppressing and immune-modulating properties. Current Molecular Medicine, 13 (4), 572-585. doi:10.2174/1566524011313040009
Peer Reviewed verified by ORBi

Schmitt, M. J., Philippidou, D., Reinsbach, S., Margue, C., Wienecke-Baldacchino, A., Nashan, D., Behrmann, I., & Kreis, S. (2012). Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell Communication and Signaling, 10. doi:10.1186/1478-811X-10-41
Peer Reviewed verified by ORBi

Reinsbach, S., Nazarov, P. V., Philippidou, D., Schmitt, M., Wienecke, A., Muller, A., Vallar, L., Behrmann, I., & Kreis, S. (2012). Dynamic regulation of microRNA expression following interferonγ- induced gene transcription. RNA Biology, 9 (7), 987-989. doi:10.4161/rna.20494
Peer Reviewed verified by ORBi

Haan, C., Rolvering, C., Raulf, F., Kapp, M., Drückes, P., Thoma, G., Behrmann, I., & Zerwes, H.-G. (2011). Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors. Chemistry and Biology, 18 (3), 314-323. doi:10.1016/j.chembiol.2011.01.012
Peer reviewed

Vollmer, S., Haan, C., & Behrmann, I. (2010). Oncostatin M up-regulates the ER chaperone Grp78/BiP in liver cells. Biochemical Pharmacology, 80 (12), 2066-2073. doi:10.1016/j.bcp.2010.07.015
Peer reviewed

Radtke, S., Wüller, S., Yang, X.-P., Lippok, B. E., Mütze, B., Mais, C., Schmitz-Van De Leur, H., Bode, J. G., Gaestel, M., Heinrich, P. C., Behrmann, I., Schaper, F. A., & Hermanns, H. M. (2010). Cross-regulation of cytokine signalling: Pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation. Journal of Cell Science, 123 (6), 947-959. doi:10.1242/jcs.065326
Peer Reviewed verified by ORBi

Entschladen, F., Altschmied, J., Baumgrass, R., Behrmann, I., Giehl, K., Hermanns, H., Huber, O., Kieser, A., Klotz, L.-O., Kubatzky, K. F., Hass, R., Janssen, O., & Friedrich, K. (2010). Signal transduction, receptors, mediators and genes: Younger than ever - The 13th meeting of the Signal Transduction Society focused on aging and immunology. Cell Communication and Signaling, 8. doi:10.1186/1478-811X-8-2
Peer Reviewed verified by ORBi

Philippidou, D., Schmitt, M., Moser, D., Margue, C., Nazarov, P. V., Muller, A., Vallar, L., Nashan, D., Behrmann, I., & Kreis, S. (2010). Signatures of MicroRNAs and selected MicroRNA target genes in human melanoma. Cancer Research, 70 (10), 4163-4173. doi:10.1158/0008-5472.CAN-09-4512
Peer Reviewed verified by ORBi

Haan, C., Behrmann, I., & Haan, S. (2010). Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases. Journal of Cellular and Molecular Medicine, 14 (3), 504-27. doi:10.1111/j.1582-4934.2010.01018.x
Peer reviewed

Friedrich, K., & Behrmann, I. (2009). Zelluläre Signalprozesse. In Biochemie und Molekularbiologie des Menschen (pp. 631-669). United States - Delaware: Elsevier.
Peer reviewed

Haan, S., Wuller, S., Kaczor, J., Rolvering, C., Nocker, T., Behrmann, I., & Haan, C. (2009). SOCS-mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling. Oncogene, 28 (34), 3069-80. doi:10.1038/onc.2009.155
Peer Reviewed verified by ORBi

Haan, C., Kroy, D. C., Wüller, S., Sommer, U., Nöcker, T., Rolvering, C., Behrmann, I., Heinrich, P. C., & Haan, S. (2009). An unusual insertion in Jak2 is crucial for kinase activity and differentially affects cytokine responses. Journal of Immunology, 182 (5), 2969-2977. doi:10.4049/jimmunol.0800572
Peer Reviewed verified by ORBi

Vollmer, S., Kappler, V., Kaczor, J., Flügel, D., Rolvering, C., Kato, N., Kietzmann, T., Behrmann, I., & Haan, C. (2009). Hypoxia-inducible factor 1alpha is up-regulated by oncostatin M and participates in oncostatin M signaling. Hepatology, 2009 (3). doi:10.1002/hep.22928
Peer Reviewed verified by ORBi

Kreis, S., Philippidou, D., Margue, C., & Behrmann, I. (10 May 2008). IL-24: a classic cytokine and/or a potential cure for cancer? Journal of Cellular and Molecular Medicine, 12 (6A), 2505-2510. doi:10.1111/j.1582-4934.2008.00372.x
Peer reviewed

Haan, S., Margue, C., Engrand, A., Rolvering, C., Schmitz-Van de Leur, H., Heinrich, P. C., Behrmann, I., & Haan, C. (2008). Dual role of the Jak1 FERM and kinase domains in cytokine receptor binding and in stimulation-dependent Jak activation. Journal of Immunology, 180 (2), 998-1007. doi:10.4049/jimmunol.180.2.998
Peer Reviewed verified by ORBi

Kreis, S., Munz, G. A., Haan, S., Heinrich, P. C., & Behrmann, I. (2008). Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases. Molecular Cancer Research, 5 (12), 1331-41. doi:10.1158/1541-7786.MCR-07-0317
Peer Reviewed verified by ORBi

Komyod, W., Böhm, M., Metze, D., Heinrich, P. C., & Behrmann, I. (2007). Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line. Molecular Cancer Research, 5 (3), 271-81. doi:10.1158/1541-7786.MCR-06-0274
Peer Reviewed verified by ORBi

Soond, S. M., Carroll, C., Townsend, P. A., Sayan, E., Melino, G., Behrmann, I., Knight, R. A., Latchman, D. S., & Stephanou, A. (2007). STAT1 regulates p73-mediated Bax gene expression. FEBS Letters, 581 (6), 1217-26. doi:10.1016/j.febslet.2007.02.049
Peer Reviewed verified by ORBi

Kreis, S., Philippidou, D., Margue, C., Rolvering, C., Haan, C., Dumoutier, L., Renauld, J.-C., & Behrmann, I. (2007). Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells. PLoS ONE, 2 (12), 1300. doi:10.1371/journal.pone.0001300
Peer Reviewed verified by ORBi

Haan, C., & Behrmann, I. (2007). A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. Journal of Immunological Methods, 318 (1-2), 11-9. doi:10.1016/j.jim.2006.07.027
Peer reviewed

Haan, C., Kreis, S., Margue, C., & Behrmann, I. (November 2006). Jaks and cytokine receptors - an intimate relationship. Biochemical Pharmacology, 72 (11), 1538-46. doi:10.1016/j.bcp.2006.04.013
Peer reviewed

van Roeyen, C. R., Ostendorf, T., Denecke, B., Bokemeyer, D., Behrmann, I., Strutz, F., Lichenstein, H. S., LaRochelle, W. J., Pena, C. E., Chaudhuri, A., & Floege, J. (2006). Biological responses to PDGF-BB versus PDGF-DD in human mesangial cells. Kidney International, 69 (8), 1393-402. doi:10.1038/sj.ki.5000332
Peer Reviewed verified by ORBi

Radtke, S., Jörissen, A., de Leur, H. S., Heinrich, P. C., & Behrmann, I. (2006). Three dileucine-like motifs within the interbox1/2 region of the human oncostatin M receptor prevent efficient surface expression in the absence of an associated Janus kinase. Journal of Biological Chemistry, 281 (7), 4024-34. doi:10.1074/jbc.M511779200
Peer Reviewed verified by ORBi

Hellerbrand, C., Mühlbauer, M., Wallner, S., Schuierer, M., Behrmann, I., Bataille, F., Weiss, T., Schölmerich, J., & Bosserhoff, A. K. (2005). Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Carcinogenesis, 27 (1), 64-72. doi:10.1093/carcin/bgi201
Peer Reviewed verified by ORBi

Wellbrock, C., Weisser, C., Hassel, J. C., Fischer, P., Becker, J., Vetter, C. S., Behrmann, I., Kortylewski, M., Heinrich, P. C., & Schartl, M. (2005). STAT5 contributes to interferon resistance of melanoma cells. Current Biology, 15 (18), 1629-39. doi:10.1016/j.cub.2005.08.036
Peer reviewed

Haan, S., Keller, J. F., Behrmann, I., Heinrich, P. C., & Haan, C. (2005). Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation. Cellular Signalling, 17 (12), 1542-50. doi:10.1016/j.cellsig.2005.03.010
Peer Reviewed verified by ORBi

Komyod, W., Bauer, U. M., Heinrich, P. C., Haan, S., & Behrmann, I. (2005). Are STATS arginine-methylated? Journal of Biological Chemistry, 280 (23), 21700-5. doi:10.1074/jbc.C400606200
Peer Reviewed verified by ORBi

Radtke, S.* , Haan, S.* , Jörissen, A.* , Hermanns, H. M., Diefenbach, S., Smyczek, T., Schmitz-Vandeleur, H., Heinrich, P. C., Behrmann, I., & Haan, C. (2005). The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression. Journal of Biological Chemistry, 280 (27), 25760-8. doi:10.1074/jbc.M500822200
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Kortylewski, M., Komyod, W., Kauffmann, M. E., Bosserhoff, A. K., Heinrich, P. C., & Behrmann, I. (2004). Interferon-gamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals. Journal of Investigative Dermatology, 122 (2), 414-22. doi:10.1046/j.0022-202X.2004.22237.x
Peer Reviewed verified by ORBi

Fischer, P., Lehmann, U., Sobota, R. M., Schmitz, J., Niemand, C., Linnemann, S., Haan, S., Behrmann, I., Yoshimura, A., Johnston, J. A., Müller-Newen, G., Heinrich, P. C., & Schaper, F. (2004). The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Biochemical Journal, 378 (Pt 2), 449-60. doi:10.1042/BJ20030893
Peer Reviewed verified by ORBi

Behrmann, I., Smyczek, T., Heinrich, P. C., Schmitz-Van de Leur, H., Komyod, W., Giese, B., Muller-Newen, G., Haan, S., & Haan, C. (2004). Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak.receptor complex to be equivalent to a receptor tyrosine kinase. Journal of Biological Chemistry, 279 (34), 35486-93. doi:10.1074/jbc.M404202200
Peer Reviewed verified by ORBi

Behrmann, I., Wallner, S., Komyod, W., Heinrich, P. C., Schuierer, M., Buettner, R., & Bosserhoff, A. K. (2003). Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. American Journal of Pathology, 163 (2), 683-90. doi:10.1016/S0002-9440(10)63695-4
Peer Reviewed verified by ORBi

Kortylewski, M., Feld, F., Krüger, K. D., Bahrenberg, G., Roth, R. A., Joost, H. G., Heinrich, P. C., Behrmann, I., & Barthel, A. (2003). Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism. Journal of Biological Chemistry, 278 (7), 5242-9. doi:10.1074/jbc.M205403200
Peer Reviewed verified by ORBi

Giese, B., Au-Yeung, C. K., Herrmann, A., Diefenbach, S., Haan, C., Küster, A., Wortmann, S. B., Roderburg, C., Heinrich, P. C., Behrmann, I., & Müller-Newen, G. (2003). Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis. Journal of Biological Chemistry, 278 (40), 39205-13. doi:10.1074/jbc.M303347200
Peer Reviewed verified by ORBi

Heinrich, P. C.* , Behrmann, I.* , Haan, S.* , Hermanns, H. M.* , Müller-Newen, G.* , & Schaper, F.*. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochemical Journal, 374 (Pt 1), 1-20. doi:10.1042/BJ20030407
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Bahrenberg, G., Behrmann, I., Barthel, A., Hekerman, P., Heinrich, P. C., Joost, H. G., & Becker, W. (2002). Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers. Molecular Endocrinology, 16 (4), 859-72. doi:10.1210/mend.16.4.0800
Peer Reviewed verified by ORBi

Lehmann, U., Schmitz, J., Weissenbach, M., Sobota, R. M., Hortner, M., Friederichs, K., Behrmann, I., Tsiaris, W., Sasaki, A., Schneider-Mergener, J., Yoshimura, A., Neel, B. G., Heinrich, P. C., & Schaper, F. (2002). SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. Journal of Biological Chemistry, 278 (1), 661-71. doi:10.1074/jbc.M210552200
Peer Reviewed verified by ORBi

Roeb, E., Schleinkofer, K., Kernebeck, T., Pötsch, S., Jansen, B., Behrmann, I., Matern, S., & Grötzinger, J. (2002). The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist. Journal of Biological Chemistry, 277 (52), 50326-32. doi:10.1074/jbc.M207446200
Peer Reviewed verified by ORBi

Greiser, J. S., Stross, C., Heinrich, P. C., Behrmann, I., & Hermanns, H. M. (2002). Orientational constraints of the gp130 intracellular juxtamembrane domain for signaling. Journal of Biological Chemistry, 277 (30), 26959-65. doi:10.1074/jbc.M204113200
Peer Reviewed verified by ORBi

Radtke, S., Hermanns, H. M., Haan, C., Schmitz-Van De Leur, H., Gascan, H., Heinrich, P. C., & Behrmann, I. (2002). Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression. Journal of Biological Chemistry, 277 (13), 11297-305. doi:10.1074/jbc.M100822200
Peer Reviewed verified by ORBi

Strobl, B., Arulampalam, V., Isharc, H., Newman, S. J., Schlaak, J. F., Watling, D., Costa-Pereira, A. P., Schaper, F., Behrmann, I., Sheehan, K. C., Schreiber, R. D., Horn, F., Heinrich, P. C., & Kerr, I. M. (2001). A completely foreign receptor can mediate an interferon-gamma-like response. EMBO Journal, 20 (19), 5431-42. doi:10.1093/emboj/20.19.5431
Peer Reviewed verified by ORBi

Hilkens, C. M., Isharc, H., Lillemeier, B. F., Strobl, B., Bates, P. A., Behrmann, I., & Kerr, I. M. (2001). A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130. FEBS Letters, 505 (1), 87-91. doi:10.1016/S0014-5793(01)02783-1
Peer Reviewed verified by ORBi

Böhm, M., Schulte, U., Funk, J. O., Raghunath, M., Behrmann, I., Kortylewski, M., Heinrich, P. C., Kues, T., Luger, T. A., & Schwarz, T. (2001). Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity. Journal of Investigative Dermatology, 117 (1), 132-40. doi:10.1046/j.0022-202x.2001.01372.x
Peer Reviewed verified by ORBi

Haan, C., Heinrich, P. C., & Behrmann, I. (2001). Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation. Biochemical Journal, 361 (Pt 1), 105-11. doi:10.1042/0264-6021:3610105
Peer Reviewed verified by ORBi

Kube, D., Holtick, U., Vockerodt, M., Ahmadi, T., Haier, B., Behrmann, I., Heinrich, P. C., Diehl, V., & Tesch, H. (2001). STAT3 is constitutively activated in Hodgkin cell lines. Blood, 98 (3), 762-70. doi:10.1182/blood.V98.3.762
Peer Reviewed verified by ORBi

Zabeau, L., Van der Heyden, J., Broekaert, D., Verhee, A., Vandekerckhove, J., Wu, S. J., Chaiken, I., Heinrich, P., Behrmann, I., & Tavernier, J. (2001). Neutralizing monoclonal antibodies can potentiate IL-5 signaling. European Journal of Immunology, 31 (4), 1087-97. doi:10.1002/1521-4141(200104)31:4<1087::AID-IMMU1087>3.0.CO;2-Q
Peer reviewed

Hermanns, H. M., Radtke, S., Schaper, F., Heinrich, P. C., & Behrmann, I. (2001). Non-redundant signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to rhe oncostatin M receptor. Journal of Biological Chemistry, 275 (52), 40742-8. doi:10.1074/jbc.M005408200
Peer Reviewed verified by ORBi

Kortylewski, M., Heinrich, P. C., Kauffmann, M. E., Böhm, M., MacKiewicz, A., & Behrmann, I. (2001). Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells. Biochemical Journal, 357 (Pt 1), 297-303. doi:10.1042/0264-6021:3570297
Peer Reviewed verified by ORBi

Kortylewski, M., Heinrich, P. C., Mackiewicz, A., & Behrmann, I. (2001). Cytokine-mediated growth inhibition of human melanoma cells. Advances in Experimental Medicine and Biology, 495, 169-72. doi:10.1007/978-1-4615-0685-0_22
Peer reviewed

Haan, C., Isharc, H., Hermanns, H. M., Schmitz-Van De Leur, H., Kerr, I. M., Heinrich, P. C., Grötzinger, J., & Behrmann, I. (2001). Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction. Journal of Biological Chemistry, 276 (40), 37451-8. doi:10.1074/jbc.M106135200
Peer Reviewed verified by ORBi

Haan, C., Hermanns, H. M., Heinrich, P. C., & Behrmann, I. (2001). A single amino acid substitution (Trp(666)-->Ala) in the interbox1/2 region of the interleukin-6 signal transducer gp130 abrogates binding of JAK1, and dominantly impairs signal transduction. Biochemical Journal, 349 (Pt 1), 261-6. doi:10.1042/0264-6021:3490261
Peer Reviewed verified by ORBi

Hermanns, H. M., Radtke, S., Haan, C., Schmitz-Van de Leur, H., Tavernier, J., Heinrich, P. C., & Behrmann, I. (2000). Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Journal of Immunology, 163 (12), 6651-8.
Peer Reviewed verified by ORBi

Anhuf, D., Weissenbach, M., Schmitz, J., Sobota, R., Hermanns, H. M., Radtke, S., Linnemann, S., Behrmann, I., Heinrich, P. C., & Schaper, F. (2000). Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation. Journal of Immunology, 165 (5), 2535-43. doi:10.4049/jimmunol.165.5.2535
Peer Reviewed verified by ORBi

Terstegen, L., Maassen, B. G., Radtke, S., Behrmann, I., Schaper, F., Heinrich, P. C., Graeve, L., & Gatsios, P. (2000). Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA. FEBS Letters, 478 (1-2), 100-4. doi:10.1016/S0014-5793(00)01826-3
Peer Reviewed verified by ORBi

Thiel, S., Sommer, U., Kortylewski, M., Haan, C., Behrmann, I., Heinrich, P. C., & Graeve, L. (2000). Termination of IL-6-induced STAT activation is independent of receptor internalization but requires de novo protein synthesis. FEBS Letters, 470 (1), 15-9. doi:10.1016/S0014-5793(00)01276-X
Peer Reviewed verified by ORBi

Behrmann, I., Hermanns, H. M., Haan, C., Kortylewski, M., Radtke, S., Greiser, J. S., & Heinrich, P. C. (2000). Signalling of interleukin-6 type cytokines via gp130, leukemia inhibitory factor (LIF) receptor and oncostatin M receptor. European Cytokine Network, 11 (3), 491-2.
Peer Reviewed verified by ORBi

Roeb, E., Behrmann, I., Grötzinger, J., Breuer, B., & Matern, S. (2000). An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist. FASEB Journal, 14 (12), 1671-3. doi:10.1096/fj.99-0947fje
Peer Reviewed verified by ORBi

Haan, S., Kortylewski, M., Behrmann, I., Müller-Esterl, W., Heinrich, P. C., & Schaper, F. (2000). Cytoplasmic STAT proteins associate prior to activation. Biochemical Journal, 345 Pt 3, 417-21. doi:10.1042/0264-6021:3450417
Peer Reviewed verified by ORBi

Kortylewski, M., Heinrich, P. C., Mackiewicz, A., Schniertshauer, U., Klingmüller, U., Nakajima, K., Hirano, T., Horn, F., & Behrmann, I. (1999). Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Oncogene, 18 (25), 3742-53. doi:10.1038/sj.onc.1202708
Peer Reviewed verified by ORBi

Thiel, S., Behrmann, I., Timmermann, A., Dahmen, H., Müller-Newen, G., Schaper, F., Tavernier, J., Pitard, V., Heinrich, P. C., & Graeve, L. (1999). Identification of a Leu-lle internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptor. Biochemical Journal, 339 (Pt 1), 15-9. doi:10.1042/0264-6021:3390015
Peer Reviewed verified by ORBi

Heinrich, P. C., Behrmann, I., Müller-Newen, G., Schaper, F., & Graeve, L. (1998). Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochemical Journal, 334 (Pt 2), 297-314. doi:10.1042/bj3340297
Peer Reviewed verified by ORBi

Thiel, S., Behrmann, I., Dittrich, E., Muys, L., Tavernier, J., Wijdenes, J., Heinrich, P. C., & Graeve, L. (1998). Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway. Biochemical Journal, 330 (Pt 1), 47-54. doi:10.1042/bj3300047
Peer Reviewed verified by ORBi

Behrmann, I., Janzen, C., Gerhartz, C., Schmitz-Van de Leur, H., Hermanns, H., Heesel, B., Graeve, L., Horn, F., Tavernier, J., & Heinrich, P. C. (1997). A single STAT recruitment module in a chimeric cytokine receptor complex is sufficient for STAT activation. Journal of Biological Chemistry, 272 (8), 5269-74. doi:10.1074/jbc.272.8.5269
Peer Reviewed verified by ORBi

Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1996). Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO Journal, 14 (22), 5579-88. doi:10.1002/j.1460-2075.1995.tb00245.x
Peer Reviewed verified by ORBi

Krammer, P. H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., & Westendorp, M. O. (1995). The role of APO-1-mediated apoptosis in the immune system. Immunological Reviews, 142, 175-91. doi:10.1111/j.1600-065X.1994.tb00889.x
Peer Reviewed verified by ORBi

Dhein, J., Behrmann, I., Daniel, P. T., Debatin, K. M., Klas, C., Möller, P., Oehm, A., Trauth, B. C., Walczak, H., & Krammer, P. H. (1995). APO-I-mediated apoptosis in normal and malignant lymphocytes. Biochemical Society Transactions, 22 (3), 598-600. doi:10.1042/bst0220598
Peer reviewed

Behrmann, I., Walczak, H., & Krammer, P. H. (1995). Structure of the human APO-1 gene. European Journal of Immunology, 24 (12), 3057-62. doi:10.1002/eji.1830241221
Peer reviewed

Krammer, P. H., Behrmann, I., Daniel, P. T., Dhein, J., & Debatin, K. M. (1994). Regulation of apoptosis in the immune system. Current Opinion in Immunology, 6 (2), 279-89. doi:10.1016/0952-7915(94)90102-3
Peer reviewed

Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., & Trauth, B. C. (1992). Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. Journal of Biological Chemistry, 267 (15), 10709-15.
Peer Reviewed verified by ORBi

Behrmann, I., Hillemann, D., Pühler, A., Strauch, E., & Wohlleben, W. (1990). Overexpression of a Streptomyces viridochromogenes gene (glnII) encoding a glutamine synthetase similar to those of eucaryotes confers resistance against the antibiotic phosphinothricyl-alanyl-alanine. Journal of Bacteriology, 172 (9), 5326-34. doi:10.1128/jb.172.9.5326-5334.1990
Peer Reviewed verified by ORBi

Contact ORBilu